26-27 June, 2026
The event is divided into 5 different sessions
The first session
will focus on the recent advancements in COPD and its comorbidities, and in particular the need to better characterize the different phenotypes included under the umbrella of the term COPD, novel therapies for COPD and the major cardiovascular risk in patients with COPD.
The second session
will focus on asthma as disease of both central and peripheral airways the need of integration of traditional pharmacological inhalation treatments with systemic agents and/or biologics, the third the ongoing research focused on mechanisms rather that clinical treatable treats
The third session
will be devoted to the importance and impact of small airways dysfunction for chronic airways diseases, and in particular on the fundamental role of inhalers but also of their environmental impact, its complex impact of respiratory and non-respiratory components of chronic airways diseases, and last, but not least, how can AI help us to understand the role of small airways dysfunction
The forth session
will be devoted to the novel discoveries in the field of pathology of chronic airways diseases, and particularly the importance of mucus plugs, and mucociliary clearance.
The fifth session
will be devoted to bronchiectasis that in the last 15 years have been discovered to represent not only a treatable trait of other chronic airways diseases but also an independent treatable disease
Scientific Referees
Prof. Dario Olivieri
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Prof. Gaetano Caramori
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Venue
Where
Viale Piacenza, 12/c,
43100 Parma PR
When
Saturday to Sunday
June 26-27, 2026